Proposed FDA/Industry "Least Burdensome" Panel Will Not Include Agency
This article was originally published in The Gray Sheet
Executive Summary
An industry-only task force will be charged with drafting tentative guidelines to outline "least burdensome" avenues for industry and FDA reviewers in the submission of premarket applications, industry reps and FDA concluded at a Jan. 4 meeting in Rockville, Maryand.